ISCO

International Stem Cell (QX) Stock Price

0.48
0.00 (0.0%)
0.48
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
International Stem Cell Corporation (QX) ISCO OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.48 15:36:27
Open Price Low Price High Price Close Price Previous Close
0.44 0.44 0.48 0.48 0.48
Bid Price Ask Price Spread News
0.42 0.50 0.08 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7 445 $ 0.453333 $ 202 2,020 0.27 - 1.20
Last Trade Time Type Quantity Stock Price Currency
15:36:27 100 $ 0.48 USD

International Stem Cell (QX) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.62M 7.54M 2.19M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
979.00 $ - 0.00% - -

more financials information »

International Stem Cell (QX) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ISCO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.42150.580.420.50566964,2640.058513.88%
1 Month0.5950.610.416050.54037553,298-0.115-19.33%
3 Months0.630.650.416050.57345822,367-0.15-23.81%
6 Months0.5350.990.416050.67801623,348-0.055-10.28%
1 Year0.501.200.270.64065024,716-0.02-4.0%
3 Years1.631.900.271.145,295-1.15-70.55%
5 Years3.295.500.271.685,984-2.81-85.41%

International Stem Cell (QX) Description

International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenetic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial backgrounds, with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell?. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), and stem cell-based skin care products through its subsidiary Lifeline Skin Care (www.lifelineskincare.com).


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.